Can-Fite BioPharma's market cap is currently $14.16M. The company's EPS TTM is $-0.144; its P/E ratio is ―; Can-Fite BioPharma is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
